Authors:
SOUFIR N
AVRIL MF
CHOMPRET A
DEMENAIS F
BOMBLED J
SPATZ A
STOPPALYONNET D
BENARD J
BRESSACDEPAILLERETS B
Citation: N. Soufir et al., PREVALENCE OF P16 AND CDK4 GERMLINE MUTATIONS IN 48 MELANOMA-PRONE FAMILIES IN FRANCE (VOL 7, PG 209, 1998), Human molecular genetics, 7(5), 1998, pp. 941-941
Authors:
SOUFIR N
AVRIL MF
CHOMPRET A
DEMENAIS F
BOMBLED J
SPATZ A
STOPPALYONNET D
BENARD J
BRESSACDEPAILLERETS B
Citation: N. Soufir et al., PREVALENCE OF P16 AND CDK4 GERMLINE MUTATIONS IN 48 MELANOMA-PRONE FAMILIES IN FRANCE, Human molecular genetics, 7(2), 1998, pp. 209-216
Authors:
CAPOULADE C
BRESSACDEPAILLERETS B
LEFRERE I
RONSIN M
FEUNTEUN J
TURSZ T
WIELS J
Citation: C. Capoulade et al., OVEREXPRESSION OF MDM2, DUE TO ENHANCED TRANSLATION, RESULTS IN INACTIVATION OF WILD-TYPE P53 IN BURKITTS-LYMPHOMA CELLS, Oncogene, 16(12), 1998, pp. 1603-1610
Authors:
DRAGONDUREY MA
GOGUEL AF
LEONARD C
BERGER R
BRESSACDEPAILLERETS B
FAUVET D
BERNHEIM A
Citation: Ma. Dragondurey et al., NON-HODGKINS-LYMPHOMAS AND MYELOID DISORDERS - DELETIONS ASSOCIATED WITH T(2-5) AND T(3-5) DETECTED BY FISH, Leukemia, 12(7), 1998, pp. 1159-1162
Authors:
PAGES F
FLAM TA
VIEILLEFOND A
MOLINIE V
ABEILLE X
LAZAR V
BRESSACDEPAILLERETS B
MOSSERI V
ZERBIB M
FRIDMAN WH
DEBRE B
THIOUNN N
Citation: F. Pages et al., P53 STATUS DOES NOT PREDICT INITIAL CLINICAL-RESPONSE TO BACILLUS-CALMETTE-GUERIN INTRAVESICAL THERAPY IN T1 BLADDER-TUMORS, The Journal of urology, 159(3), 1998, pp. 1079-1084
Authors:
DIEUMEGARD B
GRANDJOUAN S
SABOURIN JC
LEBIHAN MC
LASSER P
DUVILLARD P
COUTURIER D
BRESSACDEPAILLERETS B
Citation: B. Dieumegard et al., IMMUNOHISTOCHEMICAL DETECTION OF HMSH2 AND HMLH1 AS A SCREENING-TEST IN THE TUMOR-CELLS OF COLON-CANCER FAMILY SYNDROMES, Gastroenterology, 114(4), 1998, pp. 2395-2395
Authors:
JAIS P
SABOURIN JC
BOMBLED J
ROUGIER P
LASSER P
DUVILLARD P
BENARD J
BRESSACDEPAILLERETS B
Citation: P. Jais et al., ABSENCE OF SOMATIC ALTERATIONS OF THE EB1 GENE APC-ASSOCIATED PROTEININ HUMAN SPORADIC COLORECTAL-CANCER, Gastroenterology, 114(4), 1998, pp. 2531-2531
Authors:
EISINGER F
JACQUEMIER J
CHARPIN C
STOPPALYONNET D
BRESSACDEPAILLERETS B
PEYRAT JP
LONGY M
GUINEBRETIERE JM
SAUVAN R
NOGUCHI T
BIRNBAUM D
SOBOL H
Citation: F. Eisinger et al., MUTATIONS AT BRCA1 - THE MEDULLARY BREAST-CARCINOMA REVISITED, Cancer research, 58(8), 1998, pp. 1588-1592
Authors:
JAIS P
SABOURIN JC
BOMBLED J
ROUGIER P
LASSER P
DUVILLARD P
BENARD J
BRESSACDEPAILLERETS B
Citation: P. Jais et al., ABSENCE OF SOMATIC ALTERATIONS OF THE EB1 GENE ADENOMATOUS POLYPOSIS COLI-ASSOCIATED PROTEIN IN HUMAN SPORADIC COLORECTAL CANCERS, British Journal of Cancer, 78(10), 1998, pp. 1356-1360
Authors:
CAI ZZ
CAPOULADE C
MOYRETLALLE C
AMORGUERET M
FEUNTEUN J
LARSEN AK
BRESSACDEPAILLERETS B
CHOUAIB S
Citation: Zz. Cai et al., RESISTANCE OF MCF7 HUMAN BREAST-CARCINOMA CELLS TO TNF-INDUCED CELL-DEATH IS ASSOCIATED WITH LOSS OF P53 FUNCTION, Oncogene, 15(23), 1997, pp. 2817-2826
Authors:
SEROVASINILNIKOVA OM
BOUTRAND L
STOPPALYONNET D
BRESSACDEPAILLERETS B
DUBOIS V
LASSET C
JANIN N
BIGNON YJ
LONGY M
MAUGARD C
LIDEREAU R
LEROUX D
FREBOURG T
MAZOYER S
LENOIR GM
Citation: Om. Serovasinilnikova et al., BRCA2 MUTATIONS IN HEREDITARY BREAST AND OVARIAN-CANCER IN FRANCE, American journal of human genetics, 60(5), 1997, pp. 1236-1239
Citation: B. Bressacdepaillerets, FLAT POLYPOSIS, ATTENUATED POLYPOSIS - MO LECULAR DIAGNOSIS, La Semaine des hopitaux de Paris, 72(19-20), 1996, pp. 587-588
Authors:
SOBOL A
STOPPALYONNET D
BRESSACDEPAILLERETS B
PEYRAT JP
KERANGUEVEN F
JANIN N
NOGUCHI T
EISINGER F
GUINEBRETIERE JM
JACQUEMIER J
BIRNBAUM D
Citation: A. Sobol et al., TRUNCATION AT CONSERVED TERMINAL REGIONS OF BRCA1 PROTEIN IS ASSOCIATED WITH HIGHLY PROLIFERATING HEREDITARY BREAST CANCERS, Cancer research, 56(14), 1996, pp. 3216-3219
Authors:
VASSAL G
TERRIERLACOMBE MJ
BISSERY MC
VENUAT AM
GYERGYAY F
BENARD J
MORIZET J
BOLAND I
ARDOUIN P
BRESSACDEPAILLERETS B
GOUYETTE A
Citation: G. Vassal et al., THERAPEUTIC ACTIVITY OF CPT-11, A DNA-TOPOISOMERASE-I INHIBITOR, AGAINST PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR AND NEUROBLASTOMA XENOGRAFTS, British Journal of Cancer, 74(4), 1996, pp. 537-545
Authors:
LALLE P
MOYRETLALLE C
WANG Q
VIALLE JM
NAVARRO C
BRESSACDEPAILLERETS B
MAGAUD JP
OZTURK M
Citation: P. Lalle et al., GENOMIC STABILITY AND WILD-TYPE P53 FUNCTION OF LYMPHOBLASTOID-CELLS WITH GERM-LINE P53 MUTATION, Oncogene, 10(12), 1995, pp. 2447-2454
Authors:
TILKIN AF
LUBIN R
SOUSSI T
LAZAR V
JANIN N
MATHIEU MC
LEFRERE I
CARLU C
ROY M
KAYIBANDA M
BELLET D
GUILLET JG
BRESSACDEPAILLERETS B
Citation: Af. Tilkin et al., PRIMARY PROLIFERATIVE T-CELL RESPONSE TO WILD-TYPE P53 PROTEIN IN PATIENTS WITH BREAST-CANCER, European Journal of Immunology, 25(6), 1995, pp. 1765-1769
Authors:
LAZAR V
GRANDJOUAN S
BOGNEL C
COUTURIER D
ROUGIER P
BELLET D
BRESSACDEPAILLERETS B
Citation: V. Lazar et al., ACCUMULATION OF MULTIPLE MUTATIONS IN TUMOR-SUPPRESSOR GENES DURING COLORECTAL TUMORIGENESIS IN HNPCC PATIENTS, Human molecular genetics, 3(12), 1994, pp. 2257-2260
Citation: B. Bressacdepaillerets, A NEW GENE WHICH IS FREQUENTLY INACTIVED IN HUMAN CANCERS - THE P16 PROTEIN-A CELL-CYCLE REGULATOR, Bulletin du cancer, 81(10), 1994, pp. 853-856